| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/978-1-61737-957-4_11 |
| P953 | full work available online at | http://link.springer.com/content/pdf/10.1007/978-1-61737-957-4_11 |
| P698 | PubMed publication ID | 21181532 |
| P2093 | author name string | Nobuyuki Matoba | |
| Kenneth E. Palmer | |||
| Keith R. Davis | |||
| P2860 | cites work | Transient expression of antibodies in plants using syringe agroinfiltration. | Q64891855 |
| Transgenic plants | Q69856239 | ||
| Synonymous codon substitutions affect ribosome traffic and protein folding during in vitro translation | Q73327926 | ||
| Rhizosecretion of recombinant proteins from plant hairy roots | Q73559001 | ||
| ER-resident chaperone interactions with recombinant antibodies in transgenic plants | Q78631533 | ||
| An in-built proteinase inhibitor system for the protection of recombinant proteins recovered from transgenic plants | Q79407001 | ||
| New downstream processing strategy for the purification of monoclonal antibodies from transgenic tobacco plants | Q79688425 | ||
| Antibody expression in protease-deficient strains of the methylotrophic yeast Ogataea minuta | Q80832143 | ||
| Rapid system for evaluating bioproduction capacity of complex pharmaceutical proteins in plants | Q83274112 | ||
| Companion protease inhibitors to protect recombinant proteins in transgenic plant extracts | Q83274135 | ||
| Application of a PEG/salt aqueous two-phase partition system for the recovery of monoclonal antibodies from unclarified transgenic tobacco extract | Q84131876 | ||
| A plant-derived recombinant human glucocerebrosidase enzyme--a preclinical and phase I investigation | Q21092136 | ||
| The codon Adaptation Index--a measure of directional synonymous codon usage bias, and its potential applications | Q24498207 | ||
| Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component | Q24650458 | ||
| Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher's disease using a plant cell system | Q27644895 | ||
| Compilation and analysis of sequences upstream from the translational start site in eukaryotic mRNAs | Q27860573 | ||
| Current achievements in the production of complex biopharmaceuticals with moss bioreactors | Q28240997 | ||
| Moss bioreactors producing improved biopharmaceuticals | Q28248851 | ||
| Diversity of preferred nucleotide sequences around the translation initiation codon in eukaryote genomes | Q28261359 | ||
| Sequence architecture downstream of the initiator codon enhances gene expression and protein stability in plants | Q28345907 | ||
| Retracted: An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus | Q29037949 | ||
| Phase separation of integral membrane proteins in Triton X-114 solution | Q29547600 | ||
| Viral vectors for the expression of proteins in plants | Q30319869 | ||
| Immunoabsorbent nanoparticles based on a tobamovirus displaying protein A. | Q30319933 | ||
| Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants | Q30320231 | ||
| Magnifection--a new platform for expressing recombinant vaccines in plants | Q30320267 | ||
| In planta engineering of viral RNA replicons: efficient assembly by recombination of DNA modules delivered by Agrobacterium | Q30320503 | ||
| Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. | Q30356869 | ||
| Biochemical and immunological characterization of the plant-derived candidate human immunodeficiency virus type 1 mucosal vaccine CTB-MPR. | Q30373529 | ||
| Individualized human scFv vaccines produced in plants: humoral anti-idiotype responses in vaccinated mice confirm relevance to the tumor Ig. | Q30733413 | ||
| Specificity of IgG and IgE antibodies against plant and insect glycoprotein glycans determined with artificial glycoforms of human transferrin | Q30829493 | ||
| Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications | Q33233438 | ||
| Translational control of recombinant human acetylcholinesterase accumulation in plants | Q33286207 | ||
| AUG_hairpin: prediction of a downstream secondary structure influencing the recognition of a translation start site | Q33296083 | ||
| Hairy-root organ cultures for the production of human acetylcholinesterase | Q33395499 | ||
| Eukaryotic protein production in designed storage organelles | Q33403626 | ||
| Induction of protein body formation in plant leaves by elastin-like polypeptide fusions | Q33491793 | ||
| Display of peptides on the surface of tobacco mosaic virus particles. | Q37463771 | ||
| Production of antibodies in plants: approaches and perspectives | Q37463776 | ||
| Glycan engineering and production of 'humanized' glycoprotein in yeast cells | Q37472703 | ||
| Foreign protein production using plant cell and organ cultures: Advantages and limitations | Q37492938 | ||
| Disaggregating chaperones: an unfolding story. | Q37524125 | ||
| A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs. | Q37535105 | ||
| The production of biopharmaceuticals in plant systems | Q37568552 | ||
| A viral protein suppresses RNA silencing and binds silencing-generated, 21- to 25-nucleotide double-stranded RNAs | Q39644930 | ||
| Production of recombinant proteins in suspension-cultured plant cells | Q39888896 | ||
| A plant-derived human monoclonal antibody induces an anti-carbohydrate immune response in rabbits | Q40023382 | ||
| P19-dependent and P19-independent reversion of F1-V gene silencing in tomato | Q41443410 | ||
| Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals | Q42055155 | ||
| A DNA replicon system for rapid high-level production of virus-like particles in plants | Q42200961 | ||
| Expression of a chimeric uidA gene indicates that polycistronic mRNAs are efficiently translated in tobacco plastids | Q42685862 | ||
| Plant virus expression systems for transient production of recombinant allergens in Nicotiana benthamiana | Q44180049 | ||
| Preparation of extracts from plants | Q44664044 | ||
| Development of an aqueous two-phase partitioning system for fractionating therapeutic proteins from tobacco extract | Q44708968 | ||
| Cowpea mosaic virus-based systems for the expression of antigens and antibodies in plants | Q45386989 | ||
| Stability of Potato virus X expression vectors is related to insert size: implications for replication models and risk assessment | Q45408376 | ||
| Probing the microRNA and small interfering RNA pathways with virus-encoded suppressors of RNA silencing. | Q45652131 | ||
| Development of rhizosecretion as a production system for recombinant proteins from hydroponic cultivated tobacco. | Q45995835 | ||
| Optimization of Agrobacterium-mediated transient assays of gene expression in lettuce, tomato and Arabidopsis. | Q46000345 | ||
| A viral suppressor P1/HC-pro increases the GFP gene expression in agrobacterium-mediated transient assay | Q46428676 | ||
| Approaches to achieve high-level heterologous protein production in plants | Q46525035 | ||
| Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure | Q46697395 | ||
| Production of antibodies in transgenic plants | Q46882065 | ||
| Optimization of the bioprocessing conditions for scale-up of transient production of a heterologous protein in plants using a chemically inducible viral amplicon expression system. | Q46882713 | ||
| Construction of a protease-deficient strain set for the fission yeast Schizosaccharomyces pombe, useful for effective production of protease-sensitive heterologous proteins | Q46954957 | ||
| Plant pharming of a full-sized, tumour-targeting antibody using different expression strategies | Q47346670 | ||
| Increased yield of heterologous viral glycoprotein in the seeds of homozygous transgenic tobacco plants cultivated underground | Q47793719 | ||
| A protocol for expression of foreign genes in chloroplasts | Q47794492 | ||
| Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants | Q47861912 | ||
| A case study for plant-made pharmaceuticals comparing different plant expression and production systems | Q49174094 | ||
| Comparison of several Nicotiana species as hosts for high-scale Agrobacterium-mediated transient expression. | Q51131361 | ||
| Transgenic microalgae as green cell-factories | Q51728870 | ||
| Biosafety, risk assessment and regulation of plant-made pharmaceuticals. | Q53517727 | ||
| Expression of non-toxic mutant of Escherichia coli heat-labile enterotoxin in tobacco chloroplasts | Q54497923 | ||
| Is the drought over for pharming? | Q55049745 | ||
| Codon bias and heterologous protein expression | Q33979754 | ||
| Plants as bioreactors for protein production: avoiding the problem of transgene silencing. | Q34041275 | ||
| Ribosome-mediated translational pause and protein domain organization | Q34063382 | ||
| Context sequences of translation initiation codon in plants | Q34065759 | ||
| Baculovirus as versatile vectors for protein expression in insect and mammalian cells | Q34416430 | ||
| Bioproduction of therapeutic proteins in the 21st century and the role of plants and plant cells as production platforms | Q34624452 | ||
| Making an ally from an enemy: plant virology and the new agriculture | Q34766378 | ||
| Nicotiana benthamiana: its history and future as a model for plant-pathogen interactions | Q34794423 | ||
| Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants | Q34849268 | ||
| Monoclonal antibodies from plants: a new speed record | Q35075379 | ||
| Plastid transformation in higher plants | Q35891630 | ||
| Plant cell cultures for the production of recombinant proteins | Q35940957 | ||
| Advanced genetic strategies for recombinant protein expression in Escherichia coli | Q35988183 | ||
| Antibody processing and engineering in plants, and new strategies for vaccine production. | Q36055994 | ||
| Biopharmaceutical production in plants: problems, solutions and opportunities | Q36259816 | ||
| Plant-derived pharmaceuticals--the road forward | Q36313817 | ||
| Production of biopharmaceuticals and vaccines in plants via the chloroplast genome | Q36605129 | ||
| Wolman disease/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in mice | Q36745074 | ||
| Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study | Q36787005 | ||
| The human immunodeficiency virus antigen Nef forms protein bodies in leaves of transgenic tobacco when fused to zeolin | Q36794088 | ||
| From planta to pharma with glycosylation in the toolbox. | Q36817569 | ||
| Pharming and transgenic plants | Q36944229 | ||
| Growth of hairy-root cultures in various bioreactors for the production of secondary metabolites | Q37034403 | ||
| Assessment of cell engineering strategies for improved therapeutic protein production in CHO cells | Q37091960 | ||
| Viral vectors for production of recombinant proteins in plants | Q37106374 | ||
| Role of silencing suppressor proteins | Q37120595 | ||
| Preventing unintended proteolysis in plant protein biofactories | Q37152888 | ||
| Terminal sugars of Fc glycans influence antibody effector functions of IgGs | Q37209069 | ||
| Recent progress in the development of plant derived vaccines | Q37290098 | ||
| Plants as biofactories | Q37304459 | ||
| Improved virus neutralization by plant-produced anti-HIV antibodies with a homogeneous beta1,4-galactosylated N-glycan profile | Q37343940 | ||
| From Neanderthal to nanobiotech: from plant potions to pharming with plant factories | Q37381964 | ||
| Emerging methods for the production of homogeneous human glycoproteins | Q37417435 | ||
| Design of gene constructs for transgenic maize | Q37451012 | ||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 199-219 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | Methods in Molecular Biology | Q15752859 |
| P1476 | title | Recombinant protein expression in Nicotiana | |
| Recombinant Protein Expression in Nicotiana | |||
| P478 | volume | 701 |
| Q39288766 | Characterization of antibody variants during process development: The tale of incomplete processing of N-terminal secretion peptide |
| Q36785795 | Efficient single tobamoviral vector-based bioproduction of broadly neutralizing anti-HIV-1 monoclonal antibody VRC01 in Nicotiana benthamiana plants and utility of VRC01 in combination microbicides |
| Q26750828 | Environment Control to Improve Recombinant Protein Yields in Plants Based on Agrobacterium-Mediated Transient Gene Expression |
| Q58764704 | Gas Exchange Rates Decrease and Leaf Temperature Increases in Leaves Transiently Overexpressing Hemagglutinin in an -Assisted Viral Vector System |
| Q21076115 | HIV-1 neutralization profile and plant-based recombinant expression of actinohivin, an Env glycan-specific lectin devoid of T-cell mitogenic activity |
| Q49470037 | Hydroponic Treatment of Nicotiana benthamiana with Kifunensine Modifies the N-glycans of Recombinant Glycoprotein Antigens to Predominantly Man9 High-Mannose Type upon Transient Overexpression |
| Q41665586 | Monoclonal Antibody Purification (Nicotiana benthamiana Plants). |
| Q35003962 | N-glycosylation of cholera toxin B subunit in Nicotiana benthamiana: impacts on host stress response, production yield and vaccine potential. |
| Q43999900 | Permanent genome modifications in plant cells by transient viral vectors |
| Q31082919 | Production of a subunit vaccine candidate against porcine post-weaning diarrhea in high-biomass transplastomic tobacco |
| Q21090119 | Rapid and scalable plant-based production of a cholera toxin B subunit variant to aid in mass vaccination against cholera outbreaks |
| Q39289438 | Safety and immunogenicity of bacterial and tobacco plant cell line derived recombinant native and mutantEscherichia coliheat-labile toxin in chickens |
| Q34430109 | Tackling heterogeneity: a leaf disc-based assay for the high-throughput screening of transient gene expression in tobacco |
Search more.